MENU

ABUS Arbutus Biopharma Corp Forecast, Technical & Fundamental Analysis

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology
ABUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ABUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABUS is expected to report earnings to fall 33.33% to -1 cents per share on March 04

Arbutus Biopharma Corp ABUS Stock Earnings Reports
Q4'26
Est.
$-0.02
Q2'26
Est.
$-0.03
Q1'26
Beat
by $0.91
Q4'25
Missed
by $0.14
Q3'25
Missed
by $0.01
The last earnings report on August 12 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 1.24M shares outstanding, the current market capitalization sits at 828.08M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGI0.94N/A
+0.38%
Organigram Global Inc
BMRA1.71-0.01
-0.58%
Biomerica
DKL56.77-0.41
-0.72%
Delek Logistics Partners LP
RMIX9.45-0.12
-1.25%
Suncrete Inc.
PHM112.89-1.64
-1.43%
Pultegroup

ABUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with RCKT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
-3.46%
RCKT - ABUS
45%
Loosely correlated
-5.98%
BCYC - ABUS
44%
Loosely correlated
-0.83%
PCVX - ABUS
43%
Loosely correlated
-4.53%
ARRY - ABUS
43%
Loosely correlated
+2.40%
AXON - ABUS
42%
Loosely correlated
+2.54%
More
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
19
Web
http://www.arbutusbio.com
Arbutus Biopharma (ABUS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com